TerminatedPhase 3NCT02888730

Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Virginie ESCABASSE
Principal Investigator
Virginie Escabasse, MD
Creteil Hospital center (CHIC)
Intervention
Tobramycin nebulized nasally(drug)
Enrollment
86 enrolled
Eligibility
7 years · All sexes
Timeline
20172019

Study locations (6)

Collaborators

Henri Mondor University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02888730 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials